IMPACT OF UGT1A9 AND CYP2B6 POLYMORPHISM ON PHARMACOKINETICS OF PROPOFOL IN KOREAN PATIENTS.

被引：0
|
作者：
Kim, M. [1 ]
Jin, S. [1 ]
Noh, G. [1 ,2 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
[2] Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [1] Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics
    Kanaya, Akihiro
    Sato, Toshihiro
    Fuse, Nobuo
    Yamaguchi, Hiroaki
    Mano, Nariyasu
    Yamauchi, Masanori
    JOURNAL OF ANESTHESIA, 2018, 32 (02) : 236 - 243
  • [2] Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics
    Akihiro Kanaya
    Toshihiro Sato
    Nobuo Fuse
    Hiroaki Yamaguchi
    Nariyasu Mano
    Masanori Yamauchi
    Journal of Anesthesia, 2018, 32 : 236 - 243
  • [3] The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia
    Adam Mikstacki
    Oliwia Zakerska-Banaszak
    Marzena Skrzypczak-Zielinska
    Barbara Tamowicz
    Michał Prendecki
    Jolanta Dorszewska
    Marta Molinska-Glura
    Malgorzata Waszak
    Ryszard Slomski
    Journal of Applied Genetics, 2017, 58 : 213 - 220
  • [4] The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia
    Mikstacki, Adam
    Zakerska-Banaszak, Oliwia
    Skrzypczak-Zielinska, Marzena
    Tamowicz, Barbara
    Prendecki, Michal
    Dorszewska, Jolanta
    Molinska-Glura, Marta
    Waszak, Malgorzata
    Slomski, Ryszard
    JOURNAL OF APPLIED GENETICS, 2017, 58 (02) : 213 - 220
  • [5] The Effect of UGT 1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children
    Pavlovic, Dimitrije
    Budic, Ivana
    Stoimenov, Tatjana Jevtovic
    Stokanovic, Dragana
    Marjanovic, Vesna
    Stevic, Marija
    Slavkovic, Milan
    Simic, Dusica
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 13 - 27
  • [6] Individual Differences in Pharmacokinetics and Pharmacodynamics of Anesthetic Agent Propofol with Regard to CYP2B6 and UGT1A9 Genotype and Patient Age
    Kansaku, Fumiyasu
    Kumai, Toshio
    Sasaki, Kuniharu
    Yokozuka, Makito
    Shimizu, Makiko
    Tateda, Tadashi
    Murayama, Norie
    Kobayashi, Shinichi
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (05) : 532 - 537
  • [7] PREDICTING RAPID AND DELAYED PROPOFOL AWAKENING USING CYP2B6 GENE VARIANTS, UGT1A9, AGE, AND GENDER WITH MACHINE LEARNING.
    Eugene, R.
    Eugene, B.
    DiCenzo, R.
    Harrlason, A. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S66 - S66
  • [8] Effect of sex and polymorphisms of CYP2B6 and UGT1A9 on the difference between the target-controlled infusion predicted and measured plasma propofol concentration
    Fujita, Ai
    Hayamizu, Kengo
    Yoshihara, Tatsuya
    Zaitsu, Masayoshi
    Shiraishi, Fumie
    Arima, Hisatomi
    Matsuo, Kazumasa
    Shiokawa, Kanako
    Setoguchi, Hidekazu
    Sasaguri, Toshiyuki
    JA CLINICAL REPORTS, 2018, 4
  • [9] Effect of sex and polymorphisms of CYP2B6 and UGT1A9 on the difference between the target-controlled infusion predicted and measured plasma propofol concentration
    Ai Fujita
    Kengo Hayamizu
    Tatsuya Yoshihara
    Masayoshi Zaitsu
    Fumie Shiraishi
    Hisatomi Arima
    Kazumasa Matsuo
    Kanako Shiokawa
    Hidekazu Setoguchi
    Toshiyuki Sasaguri
    JA Clinical Reports, 4 (1)
  • [10] Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane
    D'Avolio, Antonio
    De Francia, Silvia
    Basile, Vittoria
    Cusato, Jessica
    De Martino, Francesca
    Pirro, Elisa
    Piccione, Francesca
    Ardito, Arianna
    Zaggia, Barbara
    Volante, Marco
    Di Perri, Giovanni
    Terzolo, Massimo
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (06): : 293 - 300
12345